Bora vs BioGend Therapeutics: monthly revenue

Monthly revenue and year-on-year change for Bora (6472) and BioGend Therapeutics (6733) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Bora ━ BioGend Therapeutics

0%+64%-30%25/1026/0126/0426/0726/10

Monthly revenue history

MonthBoraYoYBioGend TherapeuticsYoY
Oct 2026NT$1.99 billion+15.9%NT$21.4 million+24.8%
Sep 2026NT$2.33 billion+35.1%NT$21.4 million+9.5%
Aug 2026NT$2.18 billion+59.2%NT$19.3 million+9.3%
Jul 2026NT$1.9 billion+5.8%NT$19.7 million-19.5%
Jun 2026NT$2.3 billion+39.2%NT$23.8 million+63.6%
May 2026NT$2.11 billion+40.2%NT$16 million-14.5%
Apr 2026NT$1.48 billion-27.5%NT$19.6 million+0.9%
Mar 2026NT$1.53 billion+6.3%NT$16.6 million+10.4%
Feb 2026NT$1.33 billion-23.2%NT$15.3 million+1.4%
Jan 2026NT$1.14 billion-30.2%NT$23 million+32.9%
Dec 2025NT$1.66 billion-16.6%NT$23.2 million+15.5%
Nov 2025NT$1.5 billion-10.8%NT$20.1 million+43.8%
Oct 2025NT$1.72 billion-17.8%NT$17.1 million-0.8%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16